For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attached:
Serco Group plc
2. Reason for notification [Yes/No]
An acquisition or disposal of voting rights Yes
An acquisition or disposal of financial instruments which
may result in the
acquisition of shares already issued to which voting rights
are attached
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to 1 Lansdowne Partners Limited being the
notification General Partner of Lansdowne Partners
obligation: Limited Partnership
2 Lansdowne Partners International
Limited
4. Full name of shareholder(s) (if Morstan Nominees Ltd (Registered
different from 3): Shareholder)
5. Date of transaction (and date on 24 May 2010
which the
threshold is crossed or reached if
different):
6. Date on which issuer notified: 26 May 2010
7. Threshold(s) that is/are crossed or 5%
reached:
8: Notified Details
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after
shares the triggering the triggering transaction
transaction
If possible Number of Number of Number Number of Percentage of
use shares voting of voting rights voting rights
ISIN code rights shares
Direct Indirect Direct Indirect
GB0007973794 below 5% below 5% 25,179,410 5.11%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ No. of voting Percentage of
financial date conversion rights that may be voting rights
instrument period/date acquired (if the
instrument
exercised/
converted)
Total (A+B)
Number of voting rights Percentage of voting rights
25,179,410 5.11%
9. Chain of controlled undertakings through which the voting rights and /or the
financial instruments are effectively held, if applicable:
Lansdowne Partners International Limited is the parent undertaking of Lansdowne
Partners Limited
Proxy Voting:
10. Name of proxy holder: Lansdowne Partners Limited
11. Number of voting rights proxy
holder will cease to hold:
12. Date on which proxy holder will
cease to hold voting rights:
13. Additional information: Serco Group plc is disclosing this
information in accordance with DTR 5.8.12
14 Contact name: Sarah Howfield, Company Secretarial
Assistant
15. Contact telephone name: 01256 744272
For notes on how to complete form TR-1 please see the FSA website.
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in shares
A: Identity of the persons or legal entity subject to the notification
obligation
Full name
(including legal form of legal
entities)
Contact address
(registered office for legal
entities)
Phone number & email
Other useful information
(at least legal representative
for legal persons)
B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information
(e.g. functional relationship
with the
person or legal entity subject
to the
notification obligation)
C: Additional information
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.